vs

Side-by-side financial comparison of BioNTech SE (BNTX) and Equinix (EQIX). Click either name above to swap in a different company.

Equinix is the larger business by last-quarter revenue ($2.4B vs $1.5B, roughly 1.6× BioNTech SE). Equinix runs the higher net margin — 11.0% vs -1.9%, a 12.8% gap on every dollar of revenue.

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.

Equinix Inc. is an American multinational company headquartered in Redwood City, California. It specialized in internet connectivity and data center colocation centers, commonly known as carrier hotels until the company converted to a real estate investment trust (REIT) in January 2015.

BNTX vs EQIX — Head-to-Head

Bigger by revenue
EQIX
EQIX
1.6× larger
EQIX
$2.4B
$1.5B
BNTX
Higher net margin
EQIX
EQIX
12.8% more per $
EQIX
11.0%
-1.9%
BNTX

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
BNTX
BNTX
EQIX
EQIX
Revenue
$1.5B
$2.4B
Net Profit
$-28.7M
$265.0M
Gross Margin
50.5%
Operating Margin
-3.1%
17.4%
Net Margin
-1.9%
11.0%
Revenue YoY
8.8%
Net Profit YoY
-22.7%
EPS (diluted)
$2.70

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BNTX
BNTX
EQIX
EQIX
Q1 26
$2.4B
Q4 25
$2.4B
Q3 25
$1.5B
$2.3B
Q2 25
$260.8M
$2.3B
Q1 25
$2.2B
Q4 24
$2.3B
Q3 24
$1.2B
$2.2B
Q2 24
$2.2B
Net Profit
BNTX
BNTX
EQIX
EQIX
Q1 26
$265.0M
Q4 25
$265.0M
Q3 25
$-28.7M
$374.0M
Q2 25
$-386.6M
$368.0M
Q1 25
$343.0M
Q4 24
$-14.0M
Q3 24
$198.1M
$297.0M
Q2 24
$301.0M
Gross Margin
BNTX
BNTX
EQIX
EQIX
Q1 26
50.5%
Q4 25
50.5%
Q3 25
50.7%
Q2 25
52.0%
Q1 25
51.3%
Q4 24
47.1%
Q3 24
50.1%
Q2 24
49.9%
Operating Margin
BNTX
BNTX
EQIX
EQIX
Q1 26
17.4%
Q4 25
17.4%
Q3 25
-3.1%
20.5%
Q2 25
-192.1%
21.9%
Q1 25
20.6%
Q4 24
4.6%
Q3 24
0.8%
19.3%
Q2 24
20.2%
Net Margin
BNTX
BNTX
EQIX
EQIX
Q1 26
11.0%
Q4 25
11.0%
Q3 25
-1.9%
16.1%
Q2 25
-148.2%
16.3%
Q1 25
15.4%
Q4 24
-0.6%
Q3 24
15.9%
13.5%
Q2 24
13.9%
EPS (diluted)
BNTX
BNTX
EQIX
EQIX
Q1 26
$2.70
Q4 25
$2.70
Q3 25
$3.81
Q2 25
$3.75
Q1 25
$3.50
Q4 24
$-0.19
Q3 24
$3.10
Q2 24
$3.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BNTX
BNTX
EQIX
EQIX
Cash + ST InvestmentsLiquidity on hand
$3.2B
Total DebtLower is stronger
Stockholders' EquityBook value
$14.2B
Total Assets
$40.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BNTX
BNTX
EQIX
EQIX
Q1 26
$3.2B
Q4 25
$3.2B
Q3 25
$2.9B
Q2 25
$4.5B
Q1 25
$3.7B
Q4 24
$3.6B
Q3 24
$3.2B
Q2 24
$2.0B
Total Debt
BNTX
BNTX
EQIX
EQIX
Q1 26
Q4 25
Q3 25
$17.3B
Q2 25
$18.1B
Q1 25
$15.9B
Q4 24
$15.3B
Q3 24
$15.4B
Q2 24
$14.5B
Stockholders' Equity
BNTX
BNTX
EQIX
EQIX
Q1 26
$14.2B
Q4 25
$14.2B
Q3 25
$14.2B
Q2 25
$14.1B
Q1 25
$13.9B
Q4 24
$13.5B
Q3 24
$13.6B
Q2 24
$12.3B
Total Assets
BNTX
BNTX
EQIX
EQIX
Q1 26
$40.1B
Q4 25
$40.1B
Q3 25
$38.1B
Q2 25
$38.8B
Q1 25
$36.1B
Q4 24
$35.1B
Q3 24
$35.4B
Q2 24
$32.9B
Debt / Equity
BNTX
BNTX
EQIX
EQIX
Q1 26
Q4 25
Q3 25
1.22×
Q2 25
1.28×
Q1 25
1.14×
Q4 24
1.13×
Q3 24
1.13×
Q2 24
1.18×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons